Secnidazole-d6(Cat No.:R051630) is a deuterated form of Secnidazole, where six hydrogen atoms are replaced with deuterium. This modification enhances the molecule’s stability and makes it an invaluable tool in pharmacokinetic and metabolic studies, particularly for the treatment of bacterial and protozoal infections. Secnidazole-d6 is extensively used in the development and validation of analytical methods, ensuring accurate measurement of drug levels in biological matrices. This is crucial for optimizing dosage forms and understanding drug behavior within the body, thereby improving therapeutic efficacy and safety in antimicrobial treatments.
Catalog Number | R051630 |
CAS Number | 1346603-27-7 |
Synonyms | α,2-Dimethyl-5-nitro-1H-imidazole-1-ethanol-d6; 1-(2-Methyl-5-nitroimidazol-1-yl)?-2-propanol-d6; Flagentyl-d6; PM 185184-d6; RP 14539-d6; |
Molecular Formula | C7H11N3O3 |
Purity | ≥95% |
Storage | Desiccate at -20C |
IUPAC Name | 1,1,1,2,3,3-hexadeuterio-3-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol |
InChI | InChI=1S/C7H11N3O3/c1-5(11)4-9-6(2)8-3-7(9)10(12)13/h3,5,11H,4H2,1-2H3/i1D3,4D2,5D |
InChIKey | KPQZUUQMTUIKBP-KUMAEYKDSA-N |
SMILES | [2H]C([2H])([2H])C([2H])(C([2H])([2H])N1C(=NC=C1[N+](=O)[O-])C)O |